Ergoteles’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,769
| Closed | -$204K | – | 1283 |
|
|
2023
Q1 | $204K | Sell |
2,769
-7,107
| -72% | -$523K | 0.01% | 1007 |
|
|
2022
Q4 | $660K | Buy |
9,876
+266
| +3% | +$17.8K | 0.02% | 602 |
|
|
2022
Q3 | $516K | Buy |
+9,610
| New | +$516K | 0.02% | 749 |
|
|
2021
Q3 | – | Sell |
-3,838
| Closed | -$314K | – | 1471 |
|
|
2021
Q2 | $314K | Sell |
3,838
-2,117
| -36% | -$173K | 0.01% | 1047 |
|
|
2021
Q1 | $566K | Buy |
+5,955
| New | +$566K | 0.02% | 463 |
|